SXTP

60 degrees pharmaceuticals, Inc.

1.100

-0.010-0.90%

After Hours: 1.080 -0.020 -1.82%19:36 10/07 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.060/1.110

TODAY RANGE1.008-1.160

VOL154.30K

MARKET CAP3.87M

52 WEEK RANGE0.8400-8.62

AVG VOL (3M)130.13K

% TURNOVER4.16%

TURNOVER--

P/E (TTM)-0.1741

% RANGE13.42%

EPS(TTM)-6.3166

P/E(FORWARD)-0.3481

P/B1.119

BVPS0.9830

DIVIDEND--

P/S0.9080

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP3.12M

SHARES OUTSTANDING3.52M

NEXT EARNINGS--

FREE FLOAT2.83M

LOT SIZE1

EX-DATE01/20/2026

News

Press Releases

Financial Reports

Profile

TipRanks·1d ago
60 Degrees Pharmaceuticals to conclude enrollment in tafenoquine study
TipRanks·1d ago
60 Degrees highlights interim tafenoquine data, caps enrollment
NASDAQ·1d ago
Babesiosis Data Readout Today As 60 Degrees Pharmaceuticals Shares Climb
TipRanks·09/14 20:32
60 Degrees Advances Babesiosis Treatment With FDA Submission
TipRanks·09/08 21:07
60 Degrees Pharmaceuticals Updates Strategy for Tick-Borne Diseases
TipRanks·08/17 15:30
Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ·08/17 09:23
60 Degrees Pharma Q2 Net Loss Widens Despite 106% Product Revenue Growth; Stock Up
Dow Jones·08/14 19:47
Press Release: 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
NASDAQ·08/11 00:05
Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates
TipRanks·08/06 21:06
60 Degrees Pharmaceuticals Shareholders Approve Key Governance Actions
NASDAQ·08/06 11:10
Merck KGaA (MKKGY) Misses Q2 Earnings Estimates
TipRanks·08/04 21:30
60 Degrees Pharmaceuticals Completes Private Placement to Raise Capital
NASDAQ·07/31 15:00
60 Degrees Pharmaceuticals Prices $1.0M Private Placement At $1.74 Per Share; Stock Down
TipRanks·07/30 18:35
60 Degrees Pharmaceuticals to sell shares and warrants in private placement
Dow Jones·07/30 18:23
Press Release: 60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules

Same Industry

Name/Symbol

Change%

Price

SXTP

McKesson

MCK

-0.56%

874.65

Biogen Inc

BIIB

+0.55%

227.60

Amgen Inc

AMGN

-3.38%

407.27

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-12.41%

0.1094

Celgene

CELG

0.00%

108.24

Lilly Eli & Co

LLY

+0.04%

Therapeuticsmd Inc

TXMD

+0.46%

2.190

Johnson & Johnson

JNJ

-0.10%

269.19

Abbvie Inc

ABBV

-0.02%

263.96

Zoetis Inc

ZTS

+0.54%

71.44

Gilead Sciences Inc

GILD

-1.87%

144.74

Novo-Nordisk A/S

NVO

+0.47%

38.80

Bristol-Myers Squibb Co

BMY

-0.70%

62.62

Pfizer

PFE

+0.29%

27.74

Alexion Pharms

ALXN

+1.70%

182.50

Sanofi FR

SNY

+0.42%

41.11

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+1.32%

145.46

Dr Reddys Labs

RDY

0.00%

12.19

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.